MBOAT7 基因多态性与经活检确诊的非酒精性脂肪性肝病患者慢性肾病之间的关联
Association Between a Polymorphism in MBOAT7 and Chronic Kidney Disease in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-09-20
本研究探讨 MBOAT7 基因多态性与经活检确诊的非酒精性脂肪性肝病(NAFLD)患者慢性肾病(CKD)的关联。NAFLD 与 CKD 共享危险因素,近期荟萃分析确认 NAFLD 是 CKD 发生的独立危险因素。已有报道显示 PNPLA3 rs738409 和 TM6SF2 rs5854292 等 NAFLD 相关基因变异与 NAFLD 患者的肾功能相关。
要点
- NAFLD 是慢性肾病发生的独立危险因素。
- PNPLA3 rs738409 和 TM6SF2 rs5854292 与 NAFLD 患者肾功能相关。
- MBOAT7 多态性与活检确诊 NAFLD 患者 CKD 的关联需进一步明确。
核心结论
- MBOAT7 基因多态性与经活检确诊的 NAFLD 患者慢性肾病之间的关联为本研究探讨主题。
研究设计与样本
- 研究设计与样本量原文未报告。
主要发现
- 近期荟萃分析确认 NAFLD 是慢性肾病发生的独立危险因素。
- PNPLA3 rs738409 和 TM6SF2 rs5854292 等基因变异已被报道与 NAFLD 患者肾功能相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nonalcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD) share risk factors, and recent meta-analysis confirmed that NAFLD is an independent risk factor for incident CKD.1 Genetic variants associated with NAFLD, such as patatin-like phospholipase domain-containing-3 (PNPLA3) rs7384092 and transmembrane 6 superfamily member 2 (TM6SF2) rs5854292,2 have been reported to be associated with renal function in NAFLD subjects.
来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。
引用
- Koo BK, An JN, Joo SK, et al. Association Between a Polymorphism in MBOAT7 and Chronic Kidney Disease in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2019. PMID: 31546054. doi:10.1016/j.cgh.2019.09.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。